Unique laser coding technology to fight falsified medicines [PDF]
European Journal of Pharmaceutical Sciences, 2018 Based on WHO statistics, counterfeit medicines represent 10% of the global drug trade. According to Directive 2011/62/EU as regards the prevention of falsified medicines from entering into the legal supply chain, a unique identification should be put on each box of drugs to be able to track and trace them.
Géza Regdon, T Smausz, B Hopp
exaly +4 more sources
Substandard and falsified medicine screening technologies [PDF]
AAPS Open, 2019 Substandard and falsified medicine screening technologies are invaluable tools for post-marketing surveillance of medicine quality, particularly in low- and middle-income countries.
Lukas Roth +2 more
doaj +2 more sources
Combatting Substandard and Falsified Medicines: A View from Rwanda [PDF]
PLoS Medicine, 2013 Agnes Binagwaho and colleagues describe Rwanda's experience of pharmacovigilance for malaria and tuberculosis, and call for a global treaty and leadership by the World Health Organization to address the global manufacture and trade in substandard and falsified medicines.
Binagwaho, Agnes +10 more
openaire +8 more sources
Perception of falsified and counterfeit medicines among adults living in Mexico City and the metropolitan area: an underappreciated health risk [PDF]
Frontiers in PharmacologyFalsified and counterfeit medicines represent a growing global public health concern and straddles business implications, and their proliferation has intensified worldwide.
Jessica Citlalli Celaya Pérez +7 more
doaj +3 more sources
Stemming the Global Trade in Falsified and Substandard Medicines [PDF]
JAMA, 2013 WHEN HIPPOCRATES ADVISED PHYSICIANS TO never give a deadly drug, he assumed they would know for sure that the medicines they prescribed were safe. Today, criminals and unscrupulous manufacturers have permeated the global pharmaceutical market, calling into question this basic assumption of clinical practice.
Gostin, Lawrence O. +2 more
openaire +4 more sources
Falsified medicines in Africa: all talk, no action
The Lancet Global Health, 2014 تسبب الأدوية والمنتجات الطبية ذات الجودة الرديئة، سواء كانت دون المستوى المطلوب أو مزيفة، اعتلالًا يمكن تجنبه، ووفيات، ومقاومة للأدوية، وفقدان الثقة في الأنظمة الصحية، خاصة في البلدان منخفضة الدخل ومتوسطة الدخل .1-3 نبلغ عن تحليل دواءين مزيفين من أنغولا ونناقش الدروس التي يمكن أن يحملها هذا الاكتشاف.
Paul N Newton +12 more
doaj +4 more sources
Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab. [PDF]
PLoS ONE, 2017 BackgroundSubstandard and falsified medical products present a serious threat to public health, especially in low- and middle-income countries. Their identification using pharmacopeial analysis is expensive and requires sophisticated equipment and highly
Albert Petersen +3 more
doaj +2 more sources
Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania [version 1; peer review: 3 approved] [PDF]
Wellcome Open Research, 2019 Introduction: Substandard and falsified medicines undermine health systems. We sought to unravel the political and economic factors which drive the production of these products, and to explain how they reach patients.
Elizabeth Pisani +5 more
doaj +2 more sources
Why falsified medicines reach patients: an analysis of political and economic factors in Romania. [PDF]
BMJ Glob Health, 2023 Introduction To protect patients against falsified medicines, countries around the world implement stringent regulations. Despite efforts to protect supply chains in the European Union (EU), authorities continue to find falsified medicine. We studied how
Nistor AL, Pisani E, Kok MO.
europepmc +3 more sources